{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:08Z","timestamp":1792782728014,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["Y-SYBLD2022MS-0142"],"award-info":[{"award-number":["Y-SYBLD2022MS-0142"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["Y-XD2019-124, Y-SY2021ZD-0110"],"award-info":[{"award-number":["Y-XD2019-124, Y-SY2021ZD-0110"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515012975"],"award-info":[{"award-number":["2024A1515012975"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82230001 and 82270199"],"award-info":[{"award-number":["82230001 and 82270199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2022YFC2502602"],"award-info":[{"award-number":["2022YFC2502602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou Science and Technology Program","award":["2024B03J1291"],"award-info":[{"award-number":["2024B03J1291"]}]},{"name":"Sun Yat-Sen University Clinical Research 5010 Program","award":["2020009"],"award-info":[{"award-number":["2020009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06724-0","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:37:46Z","timestamp":1763347066000},"page":"6251-6262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK\/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study"],"prefix":"10.1007","volume":"104","author":[{"given":"Jin-Ni","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Guo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Hua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"3","key":"6724_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.beha.2019.06.005","volume":"32","author":"E Tse","year":"2019","unstructured":"Tse E, Kwong YL (2019) NK\/T-cell lymphomas. Best Pract Res Clin Haematol 32(3):253\u2013261","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"6724_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01293-5","volume":"15","author":"E Tse","year":"2022","unstructured":"Tse E et al (2022) How we treat NK\/T-cell lymphomas. J Hematol Oncol 15(1):74","journal-title":"J Hematol Oncol"},{"issue":"3","key":"6724_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ et al (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389\u2013400","journal-title":"Lancet Oncol"},{"issue":"4","key":"6724_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J et al (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612\u2013618","journal-title":"J Clin Oncol"},{"issue":"7","key":"6724_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/leu.2015.44","volume":"29","author":"Y Yang","year":"2015","unstructured":"Yang Y et al (2015) Prognostic nomogram for overall survival in previously untreated patients with extranodal NK\/T-cell lymphoma, nasal-type: a multicenter study. Leukemia 29(7):1571\u20131577","journal-title":"Leukemia"},{"issue":"1","key":"6724_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","volume":"35","author":"SY Chen","year":"2021","unstructured":"Chen SY et al (2021) Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia 35(1):130\u2013142","journal-title":"Leukemia"},{"issue":"1","key":"6724_CR7","first-page":"27","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The Emerg Hallm Cancer Metabolism Cell Metab 23(1):27\u201347","journal-title":"The Emerg Hallm Cancer Metabolism Cell Metab"},{"issue":"1","key":"6724_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT et al (2020) Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab 31(1):62\u201376","journal-title":"Cell Metab"},{"issue":"11","key":"6724_CR9","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1158\/1055-9965.EPI-08-1248","volume":"18","author":"J Ahn","year":"2009","unstructured":"Ahn J et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11):2814\u20132821","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"6724_CR10","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-07-0212","volume":"67","author":"U Lim","year":"2007","unstructured":"Lim U et al (2007) Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma. Cancer Res 67(11):5569\u20135574","journal-title":"Cancer Res"},{"issue":"2","key":"6724_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10428194.2021.1992618","volume":"63","author":"J Fortuny","year":"2022","unstructured":"Fortuny J et al (2022) Serum lipid trajectories in the years before a lymphoma diagnosis. Leuk Lymphoma 63(2):291\u2013303","journal-title":"Leuk Lymphoma"},{"key":"6724_CR12","first-page":"1281","volume":"9","author":"Q Quan","year":"2016","unstructured":"Quan Q et al (2016) Decreased Apolipoprotein A-I level indicates poor prognosis in extranodal natural killer\/T-cell lymphoma, nasal type. Onco Targets Ther 9:1281\u20131290","journal-title":"Onco Targets Ther"},{"issue":"5","key":"6724_CR13","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/S2352-3026(24)00066-8","volume":"11","author":"XP Tian","year":"2024","unstructured":"Tian XP et al (2024) First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer\/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial. Lancet Haematol 11(5):e336\u2013e344","journal-title":"Lancet Haematol"},{"issue":"12","key":"6724_CR14","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1194\/jlr.M079012","volume":"58","author":"JA Bowden","year":"2017","unstructured":"Bowden JA et al (2017) Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-metabolites in frozen human plasma. J Lipid Res 58(12):2275\u20132288","journal-title":"J Lipid Res"},{"key":"6724_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chroma.2016.02.054","volume":"1440","author":"M Narvaez-Rivas","year":"2016","unstructured":"Narvaez-Rivas M, Zhang Q (2016) Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer. J Chromatogr A 1440:123\u2013134","journal-title":"J Chromatogr A"},{"issue":"12","key":"6724_CR16","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1021\/acs.analchem.8b01331","volume":"90","author":"Q Xuan","year":"2018","unstructured":"Xuan Q et al (2018) Development of a high coverage pseudotargeted lipidomics method based on ultra-high performance liquid chromatography-mass spectrometry. Anal Chem 90(12):7608\u20137616","journal-title":"Anal Chem"},{"issue":"8","key":"6724_CR17","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","volume":"14","author":"EA Thevenot","year":"2015","unstructured":"Thevenot EA et al (2015) Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J Proteome Res 14(8):3322\u20133335","journal-title":"J Proteome Res"},{"issue":"3","key":"6724_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J et al (2020) Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell 37(3):403\u2013419e6","journal-title":"Cancer Cell"},{"issue":"15","key":"6724_CR19","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y et al (2012) Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res 18(15):4183\u20134190","journal-title":"Clin Cancer Res"},{"issue":"10","key":"6724_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbalip.2013.04.012","volume":"1831","author":"J Huang","year":"2013","unstructured":"Huang J et al (2013) The PPARalpha agonist Fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism. Biochim Biophys Acta 1831(10):1555\u20131565","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"6724_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910698","volume":"11","author":"H Wu","year":"2019","unstructured":"Wu H et al (2019) Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol Med 11(11):e10698","journal-title":"EMBO Mol Med"},{"issue":"2","key":"6724_CR22","first-page":"291","volume":"22","author":"W Borena","year":"2011","unstructured":"Borena W et al (2011) Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control 22(2):291\u2013299","journal-title":"Cancer Causes Control"},{"issue":"6","key":"6724_CR23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/cam4.665","volume":"5","author":"R Arthur","year":"2016","unstructured":"Arthur R et al (2016) Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer Med 5(6):1307\u20131318","journal-title":"Cancer Med"},{"issue":"5","key":"6724_CR24","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505\u20131522","journal-title":"Am J Pathol"},{"issue":"1","key":"6724_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X et al (2019) Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab 30(1):143-156e5","journal-title":"Cell Metab"},{"issue":"7596","key":"6724_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W et al (2016) Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature 531(7596):651\u2013655","journal-title":"Nature"},{"issue":"5","key":"6724_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15(5):606\u2013614","journal-title":"Cell Metab"},{"issue":"6","key":"6724_CR28","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.3390\/ijms24065493","volume":"24","author":"Y Pang","year":"2023","unstructured":"Pang Y et al (2023) Metabolic reprogramming and potential therapeutic targets in lymphoma. Int J Mol Sci 24(6):5493","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6724_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","volume":"36","author":"D Yadav","year":"2003","unstructured":"Yadav D, Pitchumoni CS (2003) Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol 36(1):54\u201362","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"6724_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L et al (2021) The cancer metabolic reprogramming and immune response. Mol Cancer 20(1):28","journal-title":"Mol Cancer"},{"issue":"9","key":"6724_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.2956","volume":"15","author":"SC Huang","year":"2014","unstructured":"Huang SC et al (2014) Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 15(9):846\u2013855","journal-title":"Nat Immunol"},{"issue":"43","key":"6724_CR32","doi-asserted-by":"publisher","first-page":"70654","DOI":"10.18632\/oncotarget.12203","volume":"7","author":"XL Ma","year":"2016","unstructured":"Ma XL et al (2016) Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget 7(43):70654\u201370668","journal-title":"Oncotarget"},{"issue":"2","key":"6724_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/leu.2010.255","volume":"25","author":"J Iqbal","year":"2011","unstructured":"Iqbal J et al (2011) Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel Aurora kinase A inhibitor in vitro. Leukemia 25(2):348\u2013358","journal-title":"Leukemia"},{"issue":"8","key":"6724_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112963","volume":"42","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer. Cell Rep 42(8):112963","journal-title":"Cell Rep"},{"issue":"11","key":"6724_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42676","volume":"5","author":"VH Jayalath","year":"2022","unstructured":"Jayalath VH et al (2022) Statin use and survival among men receiving androgen-ablative therapies for advanced prostate cancer: a systematic review and meta-analysis. JAMA Netw Open 5(11):e2242676","journal-title":"JAMA Netw Open"},{"issue":"9","key":"6724_CR36","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.7150\/jca.24488","volume":"9","author":"X Lian","year":"2018","unstructured":"Lian X et al (2018) Anticancer properties of fenofibrate: a repurposing use. J Cancer 9(9):1527\u20131537","journal-title":"J Cancer"},{"issue":"2","key":"6724_CR37","first-page":"201","volume":"5","author":"K Siemianowicz","year":"2000","unstructured":"Siemianowicz K et al (2000) Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med 5(2):201\u2013205","journal-title":"Int J Mol Med"},{"issue":"11","key":"6724_CR38","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/ijc.30013","volume":"138","author":"S Borgquist","year":"2016","unstructured":"Borgquist S et al (2016) Apolipoproteins, lipids and risk of cancer. Int J Cancer 138(11):2648\u20132656","journal-title":"Int J Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06724-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06724-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06724-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:06Z","timestamp":1767485706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06724-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6724"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06724-0","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained according to the following protocols:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Approved by IRB of Sun Yat-sen University Cancer Center (B2022-479-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}